![Li Yan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Yan
Chief Tech/Sci/R&D Officer at Brii Biosciences Ltd.
Li Yan active positions
Companies | Position | Start | End |
---|---|---|---|
Brii Biosciences Ltd.
![]() Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Li Yan
Former positions of Li Yan
Companies | Position | Start | End |
---|---|---|---|
BRII BIOSCIENCES LIMITED | Chief Tech/Sci/R&D Officer | 2018-04-01 | 2023-07-04 |
GSK PLC | Corporate Officer/Principal | - | - |
Training of Li Yan
Peking University Health Science Center | Undergraduate Degree |
University of Kansas | Doctorate Degree |
Statistics
International
United States | 3 |
Cayman Islands | 2 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
BRII BIOSCIENCES LIMITED | Commercial Services |
GSK PLC | Health Technology |
Private companies | 1 |
---|---|
Brii Biosciences Ltd.
![]() Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Li Yan
- Experience